Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome

Author(s): Tatjana Kundakovic, Marina Kolundzic

Journal Name: Current Topics in Medicinal Chemistry

Volume 13 , Issue 21 , 2013

Become EABM
Become Reviewer
Call for Editor


Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called β-glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds.

Keywords: Antihypertensive, hypoglycaemic, hypolipidemic, mushrooms, metabolic syndrome, weight loss.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 01 October, 2013
Page: [2734 - 2744]
Pages: 11
DOI: 10.2174/15680266113136660196
Price: $65

Article Metrics

PDF: 13